<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20241205063953N1</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2025-01-08</date_registration>
      <primary_sponsor>Islamic Azad University</primary_sponsor>
      <public_title>High-Intensity Functional Training Combined with Hibiscus sabdariffa Supplementation and Cardiovascular Risk Factors</public_title>
      <acronym></acronym>
      <scientific_title>High-Intensity Functional Training Combined with Hibiscus sabdariffa Supplementation Improves Cardiovascular Risk Factors in Overweight and Obese Men: A Randomized Controlled Trial</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2024-08-20</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>60</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/81061</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Double blinded, Placebo: Used, Assignment: Parallel, Purpose: Treatment, Other design features: Four groups (HIFT, Hibiscus sabdariffa, combined, and control) are evaluated. HIFT sessions and daily Hibiscus sabdariffa supplementation are administered for 12 weeks, Randomization description: In this study, participants are randomly assigned to different groups, with each group receiving a specific intervention (Hibiscus tea, HIFT, or a combination of both). Random allocation will be performed using a random number table to prevent bias in group assignment, Blinding description: In this study, blinding was implemented as follows: Participant allocation to groups was performed by an independent statistician using a computer-generated randomization list, and study groups were assigned unique codes. The supplement and placebo capsules, identical in appearance, size, and color, were manufactured by a pharmaceutical company. The labeling of these capsules was conducted by a person unrelated to the study's execution. Participants were unaware of the capsule contents, and the research team, including coaches and outcome assessors, had no access to group allocation information. These measures ensured that any potential bias in data collection or outcome evaluation was minimized.</study_design>
      <phase>N/A</phase>
      <hc_freetext>Cardiovascular risk factors (Obesity, Hypertension, Dyslipidemia).</hc_freetext>
      <i_freetext>Intervention 1: Intervention group: In this group, participants undergo a high-intensity functional training (HIFT) program for 12 weeks. The program consists of three sessions per week, each lasting 45 minutes. The training includes multi-joint movements such as squats, jumps, and resistance exercises targeting the major muscle groups of the body. Intervention 2: Intervention group: In this group, participants consume 450 mg of Hibiscus sabdariffa daily for 12 weeks. The Hibiscus sabdariffa capsules are made from the dried extract of Hibiscus flowers, with each capsule containing 450 mg of the extract. Intervention 3: Intervention group: In this group, participants receive both the high-intensity functional training (HIFT) program and daily supplementation of 450 mg of Hibiscus sabdariffa for 12 weeks.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Yes - There is a plan to make this available</results_IPD_plan>
      <results_IPD_description>What will be shared:
Document Title: Anthropometric data, lipid profile, blood pressure, and inflammation markers (CRP)
Further Details: Individual participant data will be shared after de-identification. These data include information related to primary outcomes (weight, BMI, lipid profile, blood pressure, and CRP) and will be available as a dataset for further analysis

When:
Access to the data will be available for a period of 6 months following the publication of the study results

To whom:
Data and documents will be accessible only to academic and scientific researchers working in the health field. Industry professionals involved in health-related research may also request access to the data

Conditions:
The data and documents are available for scientific and health-related research purposes. Data access requests must include a clear objective for using the data. Commercial use or use outside the scientific framework is not permitted. Access to the data will be granted only after review and approval of the request

Where to obtain:
To request data and documents, please contact the research manager:
Name: Akram Jafari
Email: Jafari.skm@gmail.com

How to obtain:
Requests for data access should be submitted to the provided email  address. After reviewing the request, an approval confirmation will be sent to the requester, and the data will be shared via a secure link or in digital file format. This process typically takes 2 to 4 weeks.

Comments:
</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Akram Jafari</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Rahmatieh- Islamic Azad University Shahrekord Branch</address>
        <city>Shahrekord</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>8817630003</zip>
        <telephone>+98 383361001</telephone>
        <email>jafari.akm@gmail.com</email>
        <affiliation>Islamic Azad University</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Akram Jafari</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Rahmatieh- Islamic Azad University Shahrekord Branch</address>
        <city>Shahrekord</city>
        <country1>Ireland</country1>
        <zip>8817630003</zip>
        <telephone>+98 38 3336 1001</telephone>
        <email>jafari.akm@gmail.com</email>
        <affiliation>Islamic Azad University</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>Men aged 20-25 years with a body mass index (BMI) between 25 and 35 kg/m²
No history of regular physical activity in the past 12 months
No medical conditions contraindicating intense physical activity (e.g., heart diseases)
Willingness to participate in the study and sign an informed consent form</inclusion_criteria>
      <agemin>20 years</agemin>
      <agemax>25 years</agemax>
      <gender>Male</gender>
      <exclusion_criteria>Individuals allergic to Hibiscus sabdariffa
Use of antioxidant drugs or supplements within the past three months</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code>E66</hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword>Overweight and obesity</hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>N/A</i_code>
      <i_code>N/A</i_code>
      <i_code>N/A</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Intervention group: In this group, participants undergo a high-intensity functional training (HIFT) program for 12 weeks. The program consists of three sessions per week, each lasting 45 minutes. The training includes multi-joint movements such as squats, jumps, and resistance exercises targeting the major muscle groups of the body.</i_keyword>
      <i_keyword>Intervention group: In this group, participants consume 450 mg of Hibiscus sabdariffa daily for 12 weeks. The Hibiscus sabdariffa capsules are made from the dried extract of Hibiscus flowers, with each capsule containing 450 mg of the extract.</i_keyword>
      <i_keyword>Intervention group: In this group, participants receive both the high-intensity functional training (HIFT) program and daily supplementation of 450 mg of Hibiscus sabdariffa for 12 weeks.</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Blood pressure. Timepoint: At baseline (pre-intervention) and after 12 weeks (post-intervention). Method of measurement: using a mercury sphygmomanometer.</prim_outcome>
      <prim_outcome>Lipid Profile: total cholesterol, LDL, HDL, and triglycerides. Timepoint: At baseline (pre-intervention) and after 12 weeks (post-intervention). Method of measurement: Blood tests using enzymatic methods for total cholesterol, LDL, HDL, and triglycerides.</prim_outcome>
      <prim_outcome>CRP. Timepoint: At baseline (pre-intervention) and after 12 weeks (post-intervention). Method of measurement: Measured using the ELISA method.</prim_outcome>
      <prim_outcome>Anthropometric Variables: weight, body mass index (BMI), and body fat percentage. Timepoint: At baseline (pre-intervention) and after 12 weeks (post-intervention). Method of measurement: Weight: Measured using a digital scale - BMI: Calculated using the formula weight (kg) divided by height (m) squared - Body Fat Percentage: Measured using a Bioelectrical Impedance Analysis (BIA) device.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome></sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Islamic Azad University</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2022-04-20</approval_date>
        <contact_name>Ethics committee of Islamic Azad University Shahrekord branch</contact_name>
        <contact_address>Rahmatieh- Islamic Azad University Shahrekord Branch Shahrekord Chahar-Mahal-va-Bakhtiari Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
